We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.94B
AUM Growth
+$2.67B
Cap. Flow
+$2.4B
Cap. Flow %
40.37%
Top 10 Hldgs %
19.09%
Holding
6,103
New
843
Increased
2,477
Reduced
2,101
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$179M
3
AMZN icon
Amazon
AMZN
+$114M
4
TSLA icon
Tesla
TSLA
+$84M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$59.8M

Sector Composition

Rank Sector Weight
1 Technology 20.95%
2 Financials 11.56%
3 Healthcare 11.43%
4 Consumer Discretionary 10.98%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGM
3151
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$49K ﹤0.01%
1,702
+465
+38% +$13K
AMPE
3152
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$49K ﹤0.01%
96
+13
+16% +$6.71K
ALJJ
3153
DELISTED
ALJ Regional Holdings Inc
ALJJ
$49K ﹤0.01%
33,985
+29,154
+603% +$40.5K
AGC
3154
DELISTED
Altimeter Growth Corp
AGC
$49K ﹤0.01%
+4,208
New +$56.5K
DBX icon
3155
Dropbox
DBX
$7.55B
$48K ﹤0.01%
1,811
-1,134
-39% -$27.3K
FBIO icon
3156
Fortress Biotech
FBIO
$93.3M
$48K ﹤0.01%
906
+294
+48% +$16.6K
FBK icon
3157
FB Financial Corp
FBK
$3.1B
$48K ﹤0.01%
1,088
-2,777
-72% -$114K
IBCP icon
3158
Independent Bank Corp
IBCP
$851M
$48K ﹤0.01%
2,029
-984
-33% -$20.8K
PACK icon
3159
Ranpak Holdings
PACK
$467M
$48K ﹤0.01%
2,371
-5,399
-69% -$101K
PRTA icon
3160
Prothena Corp
PRTA
$458M
$48K ﹤0.01%
1,928
-1,453
-43% -$27.3K
RYTM icon
3161
Rhythm Pharmaceuticals
RYTM
$8.03B
$48K ﹤0.01%
2,274
+1,490
+190% +$43.2K
SRG
3162
Seritage Growth Properties
SRG
$129M
$48K ﹤0.01%
2,614
-962
-27% -$17.8K
TBPH icon
3163
Theravance Biopharma
TBPH
$880M
$48K ﹤0.01%
2,374
+943
+66% +$17.9K
TRC icon
3164
Tejon Ranch
TRC
$443M
$48K ﹤0.01%
2,898
+869
+43% +$14.3K
TRAW icon
3165
Traws Pharma
TRAW
$9M
$48K ﹤0.01%
129
-164
-56% -$61.9K
OTIC
3166
DELISTED
Otonomy, Inc.
OTIC
$48K ﹤0.01%
18,803
+18,735
+27,551% +$76.8K
PZN
3167
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$48K ﹤0.01%
4,547
-9,852
-68% -$92.7K
ALSK
3168
DELISTED
Alaska Communications Systems
ALSK
$48K ﹤0.01%
14,709
+1,501
+11% +$4.92K
WTRU
3169
DELISTED
Essential Utilities, Inc.6.00% Tangible Equity Units
WTRU
$48K ﹤0.01%
+838
New +$48.7K
AAOI icon
3170
Applied Optoelectronics
AAOI
$12.5B
$47K ﹤0.01%
5,645
+1,188
+27% +$11.9K
AIFA
3171
All In FutureTech Alliance Inc
AIFA
$19.1M
$47K ﹤0.01%
2,747
-4,137
-60% -$57.9K
AGM icon
3172
Federal Agricultural Mortgage
AGM
$2.51B
$47K ﹤0.01%
465
-1,372
-75% -$118K
CAC icon
3173
Camden National
CAC
$996M
$47K ﹤0.01%
991
-13
-1% -$545
CBAT icon
3174
CBAK Energy Technology Ltd
CBAT
$62.7M
$47K ﹤0.01%
9,155
+8,049
+728% +$52.4K
CHT icon
3175
Chunghwa Telecom
CHT
$32.9B
$47K ﹤0.01%
1,200
+206
+21% +$8.08K

Similar funds

Tower Research Capital (TRC)'s Q1 2021 Portfolio in Review

As of Q1 2021, Tower Research Capital (TRC) held 6,103 positions worth $5.94B, up 82% from $3.27B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) deployed $2.4B of net new capital in Q1 2021, opening 843 new positions and adding to 2,477 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 9.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $685M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2021 buy was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2021, an estimated $206M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $685M.
  • Tower Research Capital (TRC) fully exited ARK Genomic Revolution ETF in Q1 2021, selling an estimated $7.27M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $5.94B portfolio in Q1 2021.
  • Tower Research Capital (TRC) opened 843 new positions and closed 546 in Q1 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 82% quarter-over-quarter to $5.94B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.